AXIL Brands Signs Multi-Year Licensing Agreement with Feld Entertainment® for Monster Jam®-Branded Hearing Protection Products
New line of Monster Jam-branded earbuds, earmuffs, hearing devices, and ear plugs to be sold in U.S. distribution channels
LOS ANGELES, Feb. 19, 2025 (GLOBE NEWSWIRE) -- AXIL Brands, Inc. ('AXIL' or the 'Company'), a leader in innovative hearing protection, hearing enhancement, and Bluetooth®/wireless technology, has entered into a multi-year licensing agreement with Feld Entertainment® and Monster Jam®, the most approachable, family-friendly motorsport in the world today, for a Monster Jam-branded hearing protection product portfolio.
Under the terms of the agreement, AXIL will produce and sell new adult and youth lines of Monster Jam-branded earbuds, earmuffs, hearing devices, and ear plugs in distribution channels in the United States. The new product lines will feature the signature AXIL sound quality, hearing protection, and enhancement functionality designed for fans of all ages. They are anticipated to be available for purchase in the spring of 2025 at various shops, retail outlets, and online platforms.
"This new collaboration with Feld Entertainment for Monster Jam-branded hearing protection products reflects our commitment to superior hearing safety, while simultaneously capturing the energy and excitement of motorsports,' said AXIL CEO Jeff Toghraie. 'Together, we can offer the millions of Monster Jam fans high-quality hearing protection, allowing them to fully enjoy the thrill of the event while safeguarding their hearing."
Unexpected, unscripted, and unforgettable, Monster Jam features world-class athletes competing for championships on perfectly engineered dirt tracks that push these ever-evolving, state-of-the-art trucks to the limit. Beyond the 350 global live events each year, the Monster Jam brand extends off the track into the home through products, content, and merchandise that keeps the fun alive year-round.
'We are thrilled to be partnering with AXIL on a new line of Monster Jam-branded hearing protection,' said Jeff Bialosky, Senior Vice President of Global Partnerships and Licensing for Feld Entertainment. 'Monster Jam fans are passionate about displaying their love for the sport, and through this partnership, they'll now be able to showcase that fandom on earbuds, earmuffs, hearing devices, and ear plugs.'
About Feld Entertainment®Feld Entertainment®, family owned and operated, is the worldwide leader in producing and presenting live touring family entertainment experiences that bring people together and uplift the human spirit. Properties include Ringling Bros. and Barnum & Bailey®, Monster Jam®, Disney On Ice, Monster Energy AMA Supercross, and the SuperMotocross World Championship. Across the brand portfolio, Feld Entertainment has entertained millions of families in more than 80 countries and on six continents. For more information, see www.feldentertainment.com.
About AXIL BrandsAXIL Brands (NYSE American: AXIL) is an emerging global consumer products company. The Company is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL® brand and premium hair and skincare products under its in-house Reviv3® brand - selling products in the United States, Canada, the European Union, and throughout Asia.
To learn more, please visit the Company's AXIL® website at www.axilbrands.com and its Reviv3® website at www.reviv3.com
Forward-Looking StatementsThis press release contains a number of forward-looking statements within the meaning of the federal securities laws. The use of words such as 'anticipate,' 'believe,' 'expect,' 'continue,' 'will,' 'prepare,' 'should,' and 'focus,' among others, generally identify forward-looking statements. These forward-looking statements are based on currently available information, and management's beliefs, projections, and current expectations, and are subject to a number of significant risks and uncertainties, many of which are beyond management's control and may cause the Company's results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) the Company's ability to grow its net sales and operations, including developing new products and expanding internationally, and perform in accordance with any guidance; (ii) our ability to generate sufficient revenue to support the Company's operations and to raise additional funds or obtain other forms of financing as needed on acceptable terms, or at all; (iii) potential difficulties or delays the Company may experience in implementing its cost savings and efficiency initiatives; (iv) the Company's ability to compete effectively with other hair and skincare companies and hearing enhancement and protection companies; (v) the concentration of the Company's customers, potentially increasing the negative impact to the Company by changing purchasing or selling patterns; (vi) changes in laws or regulations in the United States and/or in other major markets, such as China, in which the Company operates, including, without limitation, with respect to taxes, tariffs, trade policies or product safety, which may increase the Company product costs and other costs of doing business, and reduce the Company's earnings; (vii) the Company's ability to engage in strategic partnerships and expand its distribution and retail channels; and (viii) the impact of unstable market and general economic conditions on the Company's business, financial condition and stock price, including inflationary cost pressures, the possibility of an economic recession and other macroeconomic factors, geopolitical events, and uncertainty, decreased discretionary consumer spending, supply chain disruptions and constraints, labor shortages, ongoing economic disruption, including the effects of the Ukraine-Russia conflict and the Israel-Hamas conflict, and other downturns in the business cycle or the economy. There can be no assurance as to any of these matters, and potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. Other important factors that may cause actual results to differ materially from those expressed in the forward-looking statements are discussed in the Company's filings with the U.S. Securities and Exchange Commission. These forward-looking statements speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.
Investor Relations:Media Relations:Todd McKnight(917) 349-2175investors@goaxil.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil Kakkis, M.D., Ph.D., the company's chief executive officer, will participate in a fireside at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025, at 10:00 a.m. ET. The live and archived webcast of the panel will be accessible from the company's website at About Ultragenyx Pharmaceutical Inc. Ultragenyx is a biopharmaceutical company committed to bringing novel products to patients for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease. The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx's strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency. For more information on Ultragenyx, please visit the company's website at: Contacts – Ultragenyx Pharmaceutical, Higa ir@
Yahoo
41 minutes ago
- Yahoo
Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Second Quarter Common Stock Distribution of $0.1280 Per Share
TORONTO, June 03, 2025 (GLOBE NEWSWIRE) -- Sprott Focus Trust, Inc. (Nasdaq-FUND) (the 'Fund' or 'FUND') has declared a quarterly distribution of $0.1280 per share on its Common Stock. The distribution, optionally payable in additional shares of Common Stock or in cash by specific stockholder election, is to be paid on June 30, 2025 to stockholders of record at the close of business on June 13, 2025 (ex-dividend on June 13, 2025). The price of shares issued for reinvestment will be determined on June 23, 2025. The Fund currently has adopted a Distribution Policy of paying quarterly distributions on its Common Stock. Distributions are being made at the annual rate of 6% of the rolling average of the prior four calendar quarter-end net asset values ('NAVs'), with the fourth quarter distribution being the greater of 1.50% of the rolling average or the minimum distribution required by IRS regulations. The policy, including the annual rate, is subject to change at the discretion of the Fund's Board of Directors. The Fund's estimated sources of the distribution to be paid on June 30, 2025 and for 2025 year-to-date are as follows: Estimated Allocations as of May 31, 2025 Distribution Per Share Net Investment Income Net Realized Short-Term Gains Net Realized Long-Term Gains Return of Capital FUND $ 0.1280 $ 0.0491 (38.36%) $ 0.0021 (1.64%) $ 0.0768 (60.00%) $ 0.0000 (0.00%) Estimated Allocations for 2025 through May 31, 2025 Distribution Per Share Net Investment Income Net Realized Short-Term Gains Net Realized Long-Term Gains Return of Capital FUND $ 0.2585 $ 0.0881 (34.08%) $ 0.0021 (0.81%) $ 0.1464 (56.65%) $ 0.0219 (8.46%) You should not draw any conclusions about the Fund's investment performance from the amount of the current distribution or from the terms of the Fund's Distribution Policy. The amounts and sources of distributions reported herein are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes. Fund Performance and Distribution Rate Information Average Annual Total Return (in relation to NAV for the 5-year period ending on 05/31/2025)1 Annualized Current Distribution Rate (expressed as a percentage of NAV as of 05/31/2025)2 Cumulative total return (in relation to NAV for the fiscal year through 05/31/2025)3 Cumulative fiscal year Distribution Rate (as a percentage of NAV as of 05/31/2025)4 FUND 11.85% 1.58% -1.38% 3.19% 1 Average Annual Total Return in relation to NAV represents the compound average of the Annual NAV Total Returns of the Fund for the five year period ended May 31, 2025. Annual NAV Total Return is the percentage change in the Fund's NAV over a year, assuming reinvestment of distributions paid. 2 The Annualized Current Distribution Rate is the current fiscal period's distribution rate annualized as a percentage of the Fund's NAV as of May 31, 2025. 3 Cumulative Total Return is the percentage change in the Fund's NAV from December 31, 2024 to May 31, 2025, assuming reinvestment of distributions paid. 4 The Cumulative Fiscal Year Distribution Rate is the dollar value of distributions for the fiscal year period (January 1, 2025 to May 31, 2025), as a percentage of the Fund's NAV as of May 31, 2025. About Sprott Focus Trust, Inc. Sprott Focus Trust, Inc. is a closed-end diversified investment management company whose shares of Common Stock are listed and traded on the Nasdaq Global Select Market. The Fund's investment goal is long-term capital growth, which it seeks by normally investing at least 65% of its assets in equity securities. For further information on the Fund, please visit our web site at: An investor should consider investment objectives, risks, charges and expenses carefully before investing. The Fund is a closed-end fund and closed-end funds do not continuously issue shares for sale as open-end mutual funds do. The Fund trades in the secondary market. Investors wishing to buy or sell shares need to place orders through an intermediary or broker. Suite 230 | 320 Post Road | Darien, Connecticut | USA 06820 | (203) 636-0977 | Contact: Glen Williams (416) 943-4394Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Willis Lease Finance Corporation Announces Offering of $596 Million in Fixed Rate Notes
COCONUT CREEK, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- Willis Lease Finance Corporation (NASDAQ: WLFC) ('WLFC' or the 'Company'), a leading lessor of commercial jet engines, announced today that its wholly-owned subsidiary, Willis Engine Structured Trust VIII ('WEST'), proposes to offer $524 million in aggregate principal amount of Series A Fixed Rate Notes (the 'Initial Series A Notes') and $72 million in aggregate principal amount of Series B Fixed Rate Notes (the 'Initial Series B Notes' and, together with the Initial Series A Notes, the 'Initial Notes'). The Notes will be secured by, among other things, WEST's direct and indirect interests in a portfolio of 62 aircraft engines and two airframes, which WEST will acquire from WLFC or its other subsidiaries pursuant to an asset purchase agreement. The net proceeds of the Notes will be primarily applied to (i) pay certain fees and expenses related to the offering of the Notes, (ii) deposit initial amounts in reserve accounts for security deposits, maintenance expenses and other expenses and (iii) pay WLFC periodically over a 270-day delivery period the consideration for the aircraft engines and the airframes acquired by WEST from WLFC in connection with the financing. WLFC and its subsidiaries will apply any net proceeds it receives to repay debt collateral by the assets and for general corporate purposes. The Notes being offered by WEST have not been and will not be registered under the Securities Act of 1933, as amended (the 'Securities Act'), or any other securities laws of any jurisdiction, and may not be offered or sold in the United States or to U.S. persons (as defined in Regulation S under the Securities Act) absent registration or an applicable exemption from registration requirements. The Notes are being offered only to persons reasonably believed to be 'qualified institutional buyers' as defined in, and in reliance on, Rule 144A under the Securities Act and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act. This news release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of, the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the Securities Act or the securities laws of any such jurisdiction. This news release is being issued pursuant to and in accordance with Rule 135c under the Securities Act. Except for historical information, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties. Do not unduly rely on forward-looking statements, which give only expectations about the future and are not guarantees. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which the forward-looking statement is based, except as required by law. Our actual results may differ materially from the results discussed in forward-looking statements. Factors that might cause such a difference include, but are not limited to: the effects on the airline industry and the global economy of events such as war, terrorist activity and global pandemics; changes in oil prices, rising inflation and other disruptions to the world markets; trends in the airline industry and our ability to capitalize on those trends, including growth rates of markets and other economic factors; risks associated with owning and leasing jet engines and aircraft; our ability to successfully negotiate equipment purchases, sales and leases, to collect outstanding amounts due and to control costs and expenses; changes in interest rates and availability of capital, both to us and our customers; our ability to continue to meet changing customer demands; regulatory changes affecting airline operations, aircraft maintenance, accounting standards and taxes; the market value of engines and other assets in our portfolio; and risks detailed in the Company's Annual Report on Form 10-K and other continuing and current reports filed with the Securities and Exchange Commission. It is advisable, however, to consult any further disclosures the Company makes on related subjects in such filings. CONTACT: Scott B. Flaherty Executive Vice President &Chief Financial Officer sflaherty@ 561.413.0112Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
